Reed Jobs, founder of the cancer-focused venture capital fund Yosemite, calls Trump's science cuts "a tragedy" with long-term ...

If mishandled, this move could undermine public trust in the FDA and squander a once-in-a-generation opportunity to lead the ...

Fixing the root causes of vaccine inequity requires long-term investments in manufacturing, regulation, and market incentives ...

Leading oncologists said AI will one day be as integrated into cancer care as it is in smartphones and self-driving cars. #STATBreakthrough ...

A change in recommending Covid vaccines for children and pregnant women would circumvent an expert panel but please many MAHA ...

The Make America Healthy Again movement is coalescing around a new effort to turn its goals into federal policy. The Trump ...

At a gene therapy conference, there was excitement about the first correction of a genetic misspelling, along with questions ...

How likely is it for President Trump's new drug-pricing plan to be implemented? And will we see a return of Elizabeth Holmes' blood-testing ambitions? All that and more on "The Readout LOUD" podcast.

Research leaders voiced concerns about attacks on diversity efforts, grant terminations, and fear among scientists at #STATBreakthrough.

Elizabeth Holmes had more resources, talent, and opportunity than most founders will ever see — and she blew it. Now, writes ...

In a world first, scientists used CRISPR to fix a baby's unique genetic mutation. The report offers hope for personalized ...

A top agency official is meeting with industry and FDA staff as he works on guidance clarifying the FDA’s expectations for ...